XML 54 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Disaggregated Revenues (Tables)
 12 Months Ended
Dec. 31, 2023
Disaggregation of Revenue [Abstract]  
Summary of disaggregation of revenue by nature
The following table summarizes the disaggregation of revenues by product or source (dollars in thousands):
 Years Ended December 31,
 202320222021
Net product sales   
Qelbree$140,192 $61,322 $9,879 
GOCOVRI119,637 104,421 9,778 
Oxtellar XR113,404 115,345 110,708 
Trokendi XR94,336 261,221 304,817 
APOKYN75,083 75,305 99,233 
Other(1)
31,281 31,818 33,089 
Total net product sales$573,933 $649,432 $567,504 
Royalty and licensing revenues33,588 17,806 12,271 
Total revenues$607,521 $667,238 $579,775 
______________________________
(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.
The following table shows the percentage of net product sales to total net product sales:
Percentage of Net Product Sales
Years Ended December 31,
202320222021
Qelbree24%9%2%
GOCOVRI21%16%2%
Oxtellar XR20%18%19%
Trokendi XR16%40%54%
APOKYN13%12%17%
Other(1)
6%5%6%
Total100%100%100%
______________________________
(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.